Bell Rock Capital’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-7,800
Closed -$242K 114
2021
Q4
$242K Buy
+7,800
New +$314K 0.18% 101

Other funds holding GDRX

Bell Rock Capital's GDRX Position: Q1 2022 in Review

Bell Rock Capital sold out of GoodRx Holdings (GDRX) in Q1 2022, closing a stake of 7,800 shares — an estimated $242K sold.

Bell Rock Capital first reported a position in GDRX in Q4 2021 and held it in 1 quarter. The position peaked at $242K in Q4 2021. 167 funds tracked by Wall St. Rank hold GDRX as of Q1 2022.

  • Bell Rock Capital reported no remaining GoodRx Holdings position as of Q1 2022 after selling out during the quarter.
  • Bell Rock Capital sold 7,800 GoodRx Holdings shares in Q1 2022, an estimated $242K.
  • Bell Rock Capital first reported a position in GoodRx Holdings in Q4 2021 and held it in 1 quarter.
  • Bell Rock Capital's GoodRx Holdings position peaked at $242K in Q4 2021.
  • 167 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2022.

Based on Bell Rock Capital's 13F filing for Q1 2022, filed 4 May 2022.